Neurodegenerative Diseases  >>  avagacestat (BMS-708163)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
avagacestat (BMS-708163) / BMS
NCT00810147 / 2008-005929-11: A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease

Checkmark P2 data
Aug 2012 - Aug 2012: P2 data
Checkmark Data
Dec 2011 - Dec 2011: Data
Checkmark Data
More
Completed
2
209
US, Europe
BMS-708163, Placebo
Bristol-Myers Squibb
Alzheimer's Disease
06/10
06/10
NCT00890890 / 2009-010067-16: A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease

Checkmark P2 data (AAICAD 2012)
Jul 2012 - Jul 2012: P2 data (AAICAD 2012)
Terminated
2
263
US, Canada, Europe
Avagacestat, BMS-708163, Placebo
Bristol-Myers Squibb
Alzheimer's Disease
07/13
07/13

Download Options